近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Dong, H., Zhang, L.*, Liu, S.*. Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy. International journal of biological sciences 18(8):3421-3434，2022.
Sheng, D., Ma, W., Zhang, R., Zhou, L., Deng, Q., Tu, J., Chen, W., Zhang, F., Gao, N., Dong, M., Wang, D., Li, F., Liu, Y., He, X., Duan, S., Zhang, L., Liu, T.*, Liu, S.*. Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization. Journal for ImmunoTherapy of Cancer (online), 2022.
Zhang, R.#, Tu, J.#, Liu, S.*. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity. Seminars in Cancer Biology 82:11-25, 2022. PMID: 33737107
Xu, J., Yang, X., Deng, Q., Yang, C., Wang, D., Jiang, G., Yao, X., He, X., Ding, J., Qiang, J., Tu, J., Zhang, R., Lei, Q., Shao, Z-M., Bian, X.*, Hu, R.*, Zhang, L.*, Liu, S.*. TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. Nature Communications 12: 4413, 2021. PMID: 34285210
Liu, C., Qiang, J., Deng, Q., Xia, J., Deng, L., Zhou, L., Wang, D., He, X., Liu, Y., Zhao, B., Lv, J., Yu, Z., Lei, Q., Shao, Z.*, Zhang, X.*, Zhang, L.*, Liu, S.* ALDH1A1 activity in tumor -initiating cells remodels myeloid-derived suppressor cells to promote breast cancer progression. Cancer Research 81(23):5919-5934, 2021. PMID: 34580061
Jiang, G.#, Tu, J.#, Zhou, L.#, Dong, M., Fan, J., Chang, Z., Zhang, L., Bian, X., Liu, S.* Single-cell transcriptomics reveal the heterogeneity and dynamic of cancer stem-like cells during breast tumor progression. Cell Death and Disease 12(11):979, 2021.
Li, F. #, Xu, J. #, Liu, S.* Cancer Stem Cells and Neovascularization. Cells 10 (5):1070, 2021.
Huang, Y.#, Wang, H., Hao, Y., Lin, H., Dong, M., Ye, J., Song, L., Wang, Y., Li, Q., Shan, B., Jiang, Y., Li, H., Shao, Z.M., Kroemer, G., Zhang, H., Bai, L., Jin, T., Wang, C., Ma, Y., Cai, Y., Ding, C., Liu, S.*,Pan, Y.*, Jiang, W.*, Zhou R.*. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nature Cell Biology 22(6):716-727, 2020.PMID:32367047
Zhang, F. #, Liu, B., Deng, Q., Sheng, D., Xu, J., He, X., Zhang, L.*, Liu, S.*. UCP1 regulates ALDH-positive breast cancer stem cells through releasing the suppression of Snail on FBP1. Cell Biol Toxicol (online), 2020. PMID:32472219
Zhang, F. #, Liu, S.*. Mechanistic insights of adipocyte metabolism in regulating breast cancer progression. Pharmacological Research 6(155):104741, 2020. PMID:32151679
Qin, Y. #, Chen, W. #, Jiang, G., Zhou, L., Yang, X., Li, H., He, X., Wang, H., Zhou, Y., Huang, S., Liu, S.*. Interfering MSN-NONO complex activated CREB signaling serves a novel therapeutic strategy for triple-negative breast cancer, Science Advances 6(8), 2020.PMID:32128390.
Zhang, L. #, Qiang, J. #, Yang, L. #, Wang, D., Adeel, R., He, X., Chen, W., Sheng , D., Zhou, L., Jiang, Y. Z., Li, T., Du, Y., Feng, J., Hu, X., Zhang, J., Hu, X. C., Shao, Z. M., Liu, S.*. IL1R2 blockade suppresses breast tumorigenesis and progression by impairing USP15-dependent BMI1 stability. Advanced Science 7(1):1901728, 2020. PMID: 31921558
Zhou， L. #, Wang, D. #, Sheng, D. #, Xu, J., Chen, W., Qin, Y., Du, R., Yang, X., He, X., Xie, N.*, Liu, S.*, Zhang, L.*. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics 10(5): 2405-2421, 2020.PMID:32104513.
Zhang, J., Yang, Y., Zhou, S., He, X., Cao, X., Wu, C., Hu, H., Qin, J., Wei, G., Wang, H., Liu, S.*, Sun, L.*. Membrane-bound TNF mediates microtubule-targeting chemotherapeutics-induced cancer cytolysis via juxtacrine inter-cancer-cell death signaling. Cell Death and Differentiation 485, 2019. PMID: 31645676
Jiang, G.#, Wang, X.#, Sheng, D., Zhou, L., Liu, Y., Xu, C., Liu, S.* and Zhang, J.*. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function. Theranostics 9(22): 6501-6516, 2019. PMID: 31588232
Jin, X. #, Xu, X-E. # *, Jiang, Y-Z. #, Liu, Y-R., Sun, W., Guo, Y-J., Ren, Y-X., Zuo, W-J., Hu, X., Huang, S-L., Shen, H-J., Lan, F., He, Y-F., Hu, G-H., Di, G-H., He, X-H., Li, D-Q., Liu, S.*, Yu, K-D.*,, Shao, Z-M.*. The endogenous retrovirus-derived long noncodingRNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science Advances 5(3): eaat9820, 2019. PMID: 30854423
Cui, B., Luo, Y., Tian, P., Peng, F., Lu, J., Yang, Y., Su, Q., Liu, B., Yu, J., Luo, X., Yin, L., Cheng, W., An, F., He, B., Liang, D., Wu, S., Chu, P., Song, L., Liu, X., Luo, H., Xu, J., Pan, Y., Wang, Y., Li, D., Huang, P., Yang, Q., Zhang, L., Zhou, B.P., Liu, S., Xu, G.,Lam, E.W.-F., Kelley, K.W. and Liu, Q.*. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. JCI 129(3):1030-1046, 2019. PMID: 30688660
Liu, J., Duan, Z., Guo, W., Zeng, L., Wu, Y., Chen, Y., Tai, F., Wang, Y., Lin, Y., Zhang, Q., He, Y., Deng J., Stewart, R., Wang, C., Lin, P., Ghaffari, S., Evers, B.M., Liu, S.*, Zhou, M-M.*, Zhou, B.*, and Shi, J.*. Targeting the BRD4/FOXO3a/CDK6 axis Sensitizes AKT Inhibition in Luminal Breast Cancer. Nature Communications 9(1):5200, 2018. PMID: 30518851
Liu, B., Du, R., Zhou L., Xu, J., Chen, S., Chen, J., Yang, X., Liu, D-X., Shao, Z-M., Zhang, L., Yu, Z., Xie, N. *, Guan, J-L.*, and Liu, S.*. miR-200c/141 regulates breast cancer stem cell heterogeneity via targeting HIPK1/β-catenin axis. Theranostics 8(21):5801-5813, 2018. PMID: 30613263
Deng, L., Gao, X., Liu, B., He, X., Xu, J., Qiang, J., Wu, Q., Liu, S.*. NMT1 inhibition modulates breast cancer progression through stress-triggered JNK pathway. Cell Death and Disease 9(12):1143, 2018. PMID: 30446635
Chen, L-L., Lin, H-P., Zhou, W-J., He, C-X., Zhang, Z-Y., Cheng, Z-L., Song, J-B., Liu, P., Chen, X-Y., Xia, Y-K., Chen, X-F., Sun, R-Q., Zhang, J-Y., Sun, Y-P., Song, L., Liu, B-J., Du, R-K., Ding, C., Lan, F., Huang, S-L., Zhou, F., Liu, S., Xiong, Y.*, Ye, D.*, Guan, K-L.*SNIP1 recruits TET2 to regulate c-MYC target genes and cellular DNA damage response. Cell Reports 25(6):1485-1500, 2018. PMID: 30404004
Chen, W., Qin, Y., Wang, D., Zhou, L., Liu, Y., Chen, S., Yin, L., Xiao, Y., Yao, X-H., Yang, X., Ma, W., Chen, W., He, X., Zhang, L., Yang, Q., Bian, X., Shao, Z-M., Liu, S.*CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. Plos Biology 16(7):e2005869, 2018. PMID: 30052635
Chen, F., Long, Q., Fu, D., Zhu, D., Ji, Y., Han, L., Zhang, B., Xu, Q., Liu, B., Li, Y., Wu, S., Yang, C., Qian, M., Xu, J., Liu, S., Cao, L., Chin, E.Y., Lam, E.W.F., Coppé, J-P., Sun, Y. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. Nature Communications 9:4315, 2018.
Liu, M., Liu, Y., Deng, L., Wang, D., He, X., Zhou, L., Wicha, M.S., Bai, F.*, Liu, S.*.Transcriptionalprofiles of differentstates of cancerstem cells in triple-negative breast cancer.Mol Cancer 17(1):65, 2018. PMID: 29471829
Du, R., Liu, B., Zhou, L., Wang, D., He, X., Xu, X., Zhang, L., Niu, C.*, Liu, S.*. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.Cell Death and Disease 9(2):126, 2018. PMID: 29374148
Wang, D., Xu, J., Liu, B., He, X., Zhou, L., Hu, X., Qiao, F., Zhang, A., Xu, X., Zhang, H., Wicha, MS., Zhang, L., Shao, Z., Liu, S.*. IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer. Cell Death and Differentiation 25(2):330-339, 2018. PMID: 29027990
Zhou, L., Sheng, D., Deng, Q., Wang, D., Liu, S.*. Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal-like triple negative breast cancer cells. Cancer Communications 38(1):57, 2018. PMID: 30249304
Zhou, L., Sheng, D., Wang, D., Ma, W., Deng, Q., Deng, L., Liu, S.*. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay. Cell Biol Toxicol (online) 2018. PMID: 30220009
Chen, W., Qin, Y., Liu, S.*. Cytokines, breast cancer stem cells(BCSCs) and chemoresistance. Clinical and Translational Medicine 7(27), 2018.
Qin, Y., Chen, W., Liu, B., Zhou, L., Deng, L., Niu, W., Bao, D., Cheng, C., Li, D., Liu, S.*, Niu, C.*. MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin. Theranostics 7(6):1663-1673, 2017.
Zhang, Y.Y. Li,C., Yao, G.F., Du, L.J., Liu, Y., Zheng, X.J., Yan, S., Sun, J.Y., Liu, Y., Liu, M.Z., Zhang, X., Wei, G., Tong, W., Chen, X., Wu, Y., Sun, S., Liu, S., Ding, Q., Yu, Y., Yin, H., Duan, S.Z.. Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway. Diabetes 66(6):1535-1547, 2017. PMID: 28325853
Wang, D., Du, R., Liu, S.* Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer. Chin J Cancer 36(1):37, 2017 PMID: 28359295
Liu, Y., Burness, M.L.*, Martin-Trevino, R., Guy, J., Bai, S., Harouaka, R., Brooks, M.D., Shang, L., Fox, A., Luther, T.K., Davis, A., Baker, T.L., Colacino, J., Clouthier, S.G., Shao, Z-M., Wicha, M.S., and Liu, S*. RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer. Clinical Cancer Research 23(2): 514-522, 2017.
京公网安备 11010802027423号